Quantitative Analysis of Tablet Ordered Mixing

Microstructure CQAs
Full field-of-view pharmaceutical tablet microstructure image showing internal phase distribution and pore network
Publication Title

Quantitative Elucidation of the Effect of Ordered Mixing in Pharmaceutical Tablets Using Correlative Microscopy-Tomography Techniques and AI-enabled Image Analysis

In low-dose tablet formulations, achieving content uniformity is of utmost importance. Conventional bulk characterization methods, such as blend uniformity testing, lack the ability to capture the structural and compositional characteristics of API within tablets. To fill this gap, we employed a correlative imaging and analysis workflow that integrates synchrotron X-ray micro-computed tomography (SyncCT), mosaic field-of-view scanning electron microscopy (mSEM), and energy-dispersive X-ray spectroscopy (EDX) methods, combined with AI-enabled image segmentation algorithms. This workflow was utilized to investigate the effect of ordered mixing, introduced by conical screening milling (comilling), on API distribution in two real-world tablets. Specifically, two tablets with identical formulations were prepared; one incorporating comilling and the other without it. The tablets were then subjected to the imaging workflow. The results showed that the comilling process significantly improved the uniformity of API distribution in the tablet through ordered mixing, as evi-denced by mSEM-EDX and SyncCT imaging. Furthermore, the API uniformity was achieved without altering the microstructural characteristics, as evidenced by consistent pore size distribution and tortuosity values between the comilled and non-comilled tablets. Overall, this study demonstrated the potential of advanced imaging and AI-based image analysis in facilitating formulation development for low-dose tablets.

Publication cover: Quantitative analysis of tablet ordered mixing microstructure

Yinshan Chen, Sruthika Baviriseaty, Prajwal Thool, Aiden Zhu, Kellie Sluga, Philip D. Yawman, Shawn Zhang, Chen Mao

Genentech and digiM Solution

AbbVie logo
AbbVie logo
Bausch Health logo
Bausch Health logo
Bristol Myers Squibb logo
Bristol Myers Squibb logo
Merck logo
Merck logo
Moderna logo
Moderna logo
Novartis logo
Novartis logo
Pfizer logo
Pfizer logo
Johnson & Johnson Innovative Medicine logo
Johnson & Johnson Innovative Medicine logo
Roche logo
Roche logo
Mirati Therapeutics logo
Mirati Therapeutics logo
Genentech logo
Genentech logo
Lonza logo
Lonza logo
AbbVie logo
AbbVie logo
Bausch Health logo
Bausch Health logo
Bristol Myers Squibb logo
Bristol Myers Squibb logo
Merck logo
Merck logo
Moderna logo
Moderna logo
Novartis logo
Novartis logo
Pfizer logo
Pfizer logo
Johnson & Johnson Innovative Medicine logo
Johnson & Johnson Innovative Medicine logo
Roche logo
Roche logo
Mirati Therapeutics logo
Mirati Therapeutics logo
Genentech logo
Genentech logo
Lonza logo
Lonza logo

Transform Your Program with Microstructure Science

Get started with a drug product digital twin.

Purple tablet dispersing into a fine particle cloud, illustrating drug microstructure disintegration